AUS
NZ
UK
CA
USA
IND
Health
ANGLE Deal Paves the Way for 'Pan-Cancer' Diagnostic
September 23, 2024 01:34 AM PDT| By Team Kalkine MediaA Major,Healthcare sector,player, ANGLE PLC has announced a significant partnership with NuProbe USA aimed at accelerating the development of a pioneering "pan-cancer" molecular sequencing assay. This advancement could revolutionize cancer diagnostic...
AstraZeneca (AZN) Experiences Notable Market Shift: Key Insights
September 20, 2024 08:02 PM PDT| By Team Kalkine MediaHeadlines,AstraZeneca,(NASDAQ:AZN),closed at $78.38, down 0.66%, compared to a minor loss in the S&P 500.,Over the past month, shares have decreased by 8.14%, trailing behind sector gains.,Upcoming earnings are anticipated to show significant year-ov...
Stryker's Latest Acquisition and Its Impact on Stock Performance
September 18, 2024 05:19 PM PDT| By Team Kalkine MediaHeadlines,Stryker Corporation has finalized the acquisition of care.ai, a company known for its AI-driven virtual care solutions.,The acquisition aims to bolster Stryker's healthcare IT and wireless medical device offerings, highlighting its focus on...
Merit Medical's WRAPSODY Trial Yields Positive Results
September 18, 2024 05:16 PM PDT| By Team Kalkine MediaHeadlines,Merit Medical Systems reported positive 6-month outcomes from the WRAPSODY trial's arteriovenous (AV) fistula arm.,The trial data, presented at the Cardiovascular and Interventional Radiological Society of Europe, supports the company's Pre...
Rockwell Medical Stock Soars 108.5% YTD: Is It a Top Performer?
September 18, 2024 05:13 PM PDT| By Team Kalkine MediaHeadlines,Rockwell Medical's stock has surged by over 108% year-to-date, significantly outpacing industry and benchmark growth.,The company has excelled against key competitors, with notable declines in EDAP TMS and IRIDEX stocks.,Rockwell Medical's...
Teladoc Sees 12% Surge Amid Growing BetterHelp Web Traffic
September 18, 2024 04:47 PM PDT| By Team Kalkine MediaHeadlines,Teladoc Health's shares increased nearly 12%, driven by improved web traffic for its BetterHelp platform.,BetterHelp saw a 12% rise in web traffic during July and August 2024, signaling a reversal after a year of decline.,Higher traffic is...
Structure Therapeutics (NASDAQ:GPCR) Announces Key Leadership Appointments to Accelerate Development
September 17, 2024 09:47 PM PDT| By Team Kalkine MediaStructure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company specializing in novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, has announced significant leadership changes aimed at enha...
Dermata Therapeutics (NASDAQ: DRMA)(NASDAQ: DRMAW) Closes Private Placement to Fund Innovative Skin Disease Treatments
September 17, 2024 09:40 PM PDT| By Team Kalkine MediaDermata Therapeutics, Inc. (NASDAQ: DRMA)(NASDAQ: DRMAW), a late-stage biotechnology company dedicated to treating medical and aesthetic skin diseases, has successfully closed its previously announced private placement. The transaction involved the i...
Novartis’ Kisqali Cuts Breast Cancer Recurrence Risk by 28%
September 17, 2024 10:54 AM PDT| By Team Kalkine MediaHeadlines,Novartis’ Kisqali (ribociclib) demonstrated a 28.5% reduction in breast cancer recurrence risk when combined with endocrine therapy, according to the NATALEE study presented at ESMO Congress 2024.,The positive data from a four-year post-hoc...
Labcorp Expands Services with Acquisition of BioReference Health
September 17, 2024 10:52 AM PDT| By Team Kalkine MediaHeadlines,Labcorp has completed its acquisition of BioReference Health’s assets, aimed at enhancing its laboratory services and testing capabilities across the U.S.,Labcorp’s shares rose by 2.1% to $225.76 following the announcement, reflecting posit...
Northwest Urgent Care (NYSE:CYH) Expands with Acquisition of 10 Arizona Urgent Care Centers
September 16, 2024 10:05 PM PDT| By Team Kalkine MediaNorthwest Urgent Care, LLC, a Tucson-based subsidiary of Community Health Systems, Inc. (NYSE:CYH), has announced a significant expansion through the acquisition of 10 urgent care centers in Arizona from Carbon Health. This strategic move will signif...
Dermata Therapeutics (NASDAQ: DRMA, DRMAW) Secures $3.5 Million in Private Placement Offering
September 16, 2024 09:11 PM PDT| By Team Kalkine MediaDermata Therapeutics, Inc. (NASDAQ: DRMA, DRMAW), a late-stage biotechnology company specializing in medical and aesthetic skin treatments, has announced a significant financing deal. The company has entered into definitive agreements to issue and se...
Foghorn Therapeutics Sees Increase Amid High Trading Volume
September 16, 2024 03:47 AM PDT| By Team Kalkine MediaIn the,Healthcare sector,, Foghorn Therapeutics Inc. experienced a 9.5% increase in its share price, closing at $9.72 during the last trading session. This rise was accompanied by a significant increase in trading volume compared to typical sessions....
Recent Diagnostics Innovations Drive Company’s Success
September 16, 2024 03:01 AM PDT| By Team Kalkine MediaIn the,healthcare sector,, Abbott Laboratories has recently experienced noteworthy developments that underscore its continued strength in a key business segment. Abbott’s recent advancements in this area have highlighted the company's ongoing commitm...
FDA Approves Roche's OCREVUS ZUNOVO for Multiple Sclerosis Treatment
September 16, 2024 01:41 AM PDT| By Team Kalkine MediaIn the,healthcare sector,, Swiss pharmaceutical company Roche has secured approval from the U.S. Food and Drug Administration (FDA) for its new treatment, OCREVUS ZUNOVO (ocrelizumab & hyaluronidase-ocsq). This approval allows the use of OCREVUS ZUNO...
Factors Driving UnitedHealth’s Recent Stock Performance
September 13, 2024 11:10 AM PDT| By Team Kalkine MediaUnitedHealth Group Incorporated has recently experienced an upward movement in its stock price, driven by several key factors within the,healthcare sector,. The company's performance reflects its ability to navigate a complex and competitive environm...
GSK's Blood Cancer Drug Receives Breakthrough Therapy Designation
September 13, 2024 03:13 AM PDT| By Team Kalkine MediaA major player of,Healthcare sector,, GSK PLC (,NYSE:GSK,) has received Breakthrough Therapy Designation (BTD) in China for its blood cancer medication, Blenrep (belantamab mafodotin). The designation, granted by the National Medical Products Adminis...
Moderna (NASDAQ:MRNA) Plans Significant Cuts to R&D Spending, Eyes Break-Even by 2028
September 12, 2024 11:08 PM PDT| By Team Kalkine MediaIn a strategic move aimed at optimizing financial performance, Moderna (NASDAQ:MRNA) has announced plans to cut its research and development (R&D) spending by 20% for the years 2025 to 2028. This reduction will bring the total R&D expenditure down to...
Moderna Restructures R&D Strategy, Anticipates $1.1B Savings
September 12, 2024 04:59 PM PDT| By Team Kalkine MediaHeadlines,- Moderna plans to streamline its research and development efforts, focusing on obtaining FDA approval for 10 key products.,- The company expects to reduce R&D expenses by $1.1 billion by 2027, with significant cost-cutting measures startin...
GSK Advances mRNA Flu Vaccine to Phase III Trials After Positive Results
September 12, 2024 03:56 AM PDT| By Team Kalkine MediaGSK PLC, a major player in the,Healthcare sector,, has reported positive initial results from its seasonal flu vaccine using mRNA technology. The FTSE 100 company announced that the phase II trial of its mRNA-based influenza vaccine has shown promisi...
